company background image
TRA logo

Traphaco HOSE:TRA Stock Report

Last Price

₫80.00k

Market Cap

₫3.3t

7D

-2.1%

1Y

-11.1%

Updated

18 Jun, 2024

Data

Company Financials +

Traphaco Joint Stock Company

HOSE:TRA Stock Report

Market Cap: ₫3.3t

TRA Stock Overview

Produces and trades in pharmaceutical products, chemicals, and medical supplies and equipment in Vietnam.

TRA fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance2/6
Financial Health6/6
Dividends4/6

Traphaco Joint Stock Company Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Traphaco
Historical stock prices
Current Share Price₫80,000.00
52 Week High₫93,900.00
52 Week Low₫75,000.00
Beta0.36
1 Month Change-1.11%
3 Month Change-2.44%
1 Year Change-11.11%
3 Year Change12.36%
5 Year Change18.52%
Change since IPO656.00%

Recent News & Updates

Recent updates

Shareholder Returns

TRAVN PharmaceuticalsVN Market
7D-2.1%-2.2%-1.3%
1Y-11.1%7.4%13.7%

Return vs Industry: TRA underperformed the VN Pharmaceuticals industry which returned 7.4% over the past year.

Return vs Market: TRA underperformed the VN Market which returned 13.7% over the past year.

Price Volatility

Is TRA's price volatile compared to industry and market?
TRA volatility
TRA Average Weekly Movement3.4%
Pharmaceuticals Industry Average Movement4.0%
Market Average Movement4.8%
10% most volatile stocks in VN Market7.5%
10% least volatile stocks in VN Market2.7%

Stable Share Price: TRA has not had significant price volatility in the past 3 months.

Volatility Over Time: TRA's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19721,481Ma Tranwww.traphaco.com.vn

Traphaco Joint Stock Company, together with its subsidiaries, produces and trades in pharmaceutical products, chemicals, and medical supplies and equipment in Vietnam. Its pharmaceutical products include vitamins and minerals, sedatives, herbal supplements, anti-inflammatory drugs, mouth-nose-throat drugs, drugs used in eye, topical treatment, analgesics and anti-inflammatory, brain supplements, antihistamines, parasitic drugs, antifungals, antibiotics, antiviral drugs, gynecological medicines, insecticides, cardiovascular medicines, gastrointestinal drugs, immune supplements and antioxidants, osteoarthritis drugs, and respiratory drugs, as well as disease prevention products. The company also offers supplements, cosmetics, and imported products.

Traphaco Joint Stock Company Fundamentals Summary

How do Traphaco's earnings and revenue compare to its market cap?
TRA fundamental statistics
Market cap₫3.32t
Earnings (TTM)₫212.09b
Revenue (TTM)₫2.23t

15.6x

P/E Ratio

1.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
TRA income statement (TTM)
Revenue₫2.23t
Cost of Revenue₫1.02t
Gross Profit₫1.21t
Other Expenses₫993.32b
Earnings₫212.09b

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)5.12k
Gross Margin54.11%
Net Profit Margin9.52%
Debt/Equity Ratio8.7%

How did TRA perform over the long term?

See historical performance and comparison

Dividends

3.8%

Current Dividend Yield

55%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.